Share Prices & Company Research

Market News

05 Feb 2019 | 14:15

Clinigen CFO Martin Abell to stand down

Pharmaceutical and services company Clinigen Group said its chief financial officer Martin Abell had resigned and would leave the business at the end of March.

He would replaced by Nick Keher, most previously head of Royal Bank of Canada's European healthcare equity research team.

Keher would take up the role from 19 March.

At 2:15pm: (LON:CLIN) Clinigen Group share price was -8.5p at 802.5p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.